STP 43RD ANNUAL SYMPOSIUM PROGRAM
Innovative Therapeutics: Biology, Toxicologic Pathology, and Regulatory Perspectives
Scientific Co-Chairs: Dharani K. Ajithdoss, BVSc, MVSc, PhD, DACVP, DACVM, Regeneron Pharmaceuticals; Elizabeth L. Buza, DVM, DACVP, University of Pennsylvania; and Kiran S. Palyada, BVSc, MVSc, PhD, DACVP, DABT, Pfizer Inc.
Continuing Education Chair: Melanie Greeley, DVM, PhD, DACVP, Charles River Laboratories
Continuing Education Co-Chair: Debra A. Tokarz, DVM, PhD, DACVP, EPL, Inc.
